secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K
Filed at:   2023-07-17T23:59:59+00:00
Accession:  0001619856-23-000096
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caribou Biosciences prices upsized $125M public offering at $6.50/sh
--------------------------------------------------------------------

- Priced 19,230,769 shares at $6.50 per share; underwriters granted 30-day option for 2,884,615 additional shares.
- Gross proceeds ~$125M; net proceeds to Caribou expected ~$116.9M after discounts and expenses.
- Offering expected to close on or about July 18, 2023; BofA, Leerink, Evercore, RBC as book-runners.
- All shares sold by Caribou; proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000161985623000096/0001619856-23-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000161985623000096/crbu-20230713.htm
  HTML page:      https://secwatch.observer/filing/0001619856-23-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer